Form D · Biotechnology
Nexome Genomics Inc.
Gaithersburg, MD · CIK 0001855069
Offering snapshot reported Apr 5, 2021 · SEC filing
- Reported sold
- Yet to sell Offering amount: $300K
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Yet to occur As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 5, 2021 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-394658
Source: Form D, filed Apr 5, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yun Sheng Tsai | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
604 S. Frederick Avenue Suite 400
Gaithersburg, MD, 20877
Gaithersburg, MD, 20877